BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10037744)

  • 1. A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene.
    Kim CH; Kim HS; Cubells JF; Kim KS
    J Biol Chem; 1999 Mar; 274(10):6507-18. PubMed ID: 10037744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine β-hydroxylase in adult rat brains.
    Fan Y; Huang J; Duffourc M; Kao RL; Ordway GA; Huang R; Zhu MY
    Neuroscience; 2011 Sep; 192():37-53. PubMed ID: 21763404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
    Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
    PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.
    Adeniran C; Yuan Y; Davis SE; Lin C; Xu J; Zhu J; Zhan CG
    ACS Chem Neurosci; 2021 May; 12(9):1519-1527. PubMed ID: 33886267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.
    Elsayed NA; Yamamoto KM; Froehlich TE
    CNS Drugs; 2020 Apr; 34(4):389-414. PubMed ID: 32133580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.
    Zhan Y; Raza MU; Yuan L; Zhu MY
    Neuroscience; 2019 Dec; 422():184-201. PubMed ID: 31698021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Berroterán-Infante N; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hartmann AM; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Mol Psychiatry; 2021 Mar; 26(3):1009-1018. PubMed ID: 31383926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage Analysis of the Chromosome 5q31-33 Region Identifies JAKMIP2 as a Risk Factor for Graves' Disease in the Chinese Han Population.
    Li J; Teng W; Yu Y; Hou X; Shan Z
    Med Sci Monit; 2019 Feb; 25():1439-1451. PubMed ID: 30796769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population.
    Lao W; Kang H; Jin G; Chen L; Chu Y; Sun J; Sun B
    BMC Infect Dis; 2017 Jul; 17(1):488. PubMed ID: 28693442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study.
    Ueda I; Kakeda S; Watanabe K; Yoshimura R; Kishi T; Abe O; Ide S; Moriya J; Katsuki A; Hori H; Iwata N; Nakamura J; Korogi Y
    PLoS One; 2016; 11(3):e0150712. PubMed ID: 26960194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Study between Norepinephrine Transporter Gene Polymorphism and Schizophrenia in a Korean Population.
    Choo M; Hwang JA; Jeon SW; Oh SY; Yoon HK; Lee HJ; Kim YK
    Psychiatry Investig; 2015 Oct; 12(4):551-8. PubMed ID: 26508968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Association between Norepinephrine Transporter Gene Polymorphisms and Personality Traits of NEO-FFI in a Japanese Population.
    Narita S; Iwahashi K; Nagahori K; Numajiri M; Yoshihara E; Ohtani N; Ishigooka J
    Psychiatry Investig; 2015 Jul; 12(3):381-7. PubMed ID: 26207133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations.
    Wang Y; Sun N; Li S; Du Q; Xu Y; Liu Z; Zhang K
    Medicine (Baltimore); 2015 Jun; 94(23):e778. PubMed ID: 26061302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study.
    Singh AB; Bousman CA; Ng CH; Byron K; Berk M
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):53-61. PubMed ID: 25912538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population.
    Li X; Sun N; Xu Y; Wang Y; Li S; Du Q; Peng J; Luo J; Zhang K
    Neural Regen Res; 2012 Sep; 7(25):1985-91. PubMed ID: 25624829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC26A4 gene polymorphism and late-onset Alzheimer's disease in a Han Chinese population from Qingdao, China.
    Zhang J; Li Y
    Neural Regen Res; 2013 Mar; 8(8):754-9. PubMed ID: 25206722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.
    Li XP; Yin JY; Wang Y; He H; Li X; Gong WJ; Chen J; Qian CY; Zheng Y; Li F; Yin T; Gong ZC; Zhou BT; Zhang Y; Xiao L; Zhou HH; Liu ZQ
    Tumour Biol; 2014 Aug; 35(8):8259-65. PubMed ID: 24852429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CR1 in Alzheimer's disease.
    Zhu XC; Yu JT; Jiang T; Wang P; Cao L; Tan L
    Mol Neurobiol; 2015 Apr; 51(2):753-65. PubMed ID: 24794147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the SLC6a2 gene promoter in major depression and panic disorder.
    Bayles R; Baker EK; Jowett JB; Barton D; Esler M; El-Osta A; Lambert G
    PLoS One; 2013; 8(12):e83223. PubMed ID: 24312678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.